Stereotaxis (STXS) Net Income towards Common Stockholders (2010 - 2026)

Stereotaxis (STXS) reported Net Income towards Common Stockholders of -$6.2 million for Q1 2026, down 0.57% year-over-year from -$6.2 million in Q1 2025, and down 5.52% quarter-over-quarter from -$5.8 million in Q4 2025.

Stereotaxis (STXS) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends

Stereotaxis (STXS) has 17 years of Net Income towards Common Stockholders data on file, last reported at -$6.2 million in Q1 2026.

  • Net Income towards Common Stockholders for Q1 2026 came in at -$6.2 million, down 0.57% year-over-year; the trailing twelve-month figure through Mar 2026 was -$23.0 million (up 13.89% YoY), and the FY2025 annual result was -$22.9 million, up 9.62% from the prior year.
  • Net Income towards Common Stockholders declined to -$6.2 million in Q1 2026 per STXS's latest filing, from -$5.8 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at -$4.1 million in Q2 2025 and troughed at -$7.8 million in Q4 2024.
  • A 5-year average of -$5.7 million and a median of -$5.7 million in 2023 frame the typical range for Net Income towards Common Stockholders.
  • The sharpest annual moves came in 2022 and 2025: Net Income towards Common Stockholders slumped 253.75% in 2022, then surged 32.71% in 2025.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$4.5 million in 2022, then retreated by 19.75% to -$5.4 million in 2023, then sank by 45.73% to -$7.8 million in 2024, then grew by 25.39% to -$5.8 million in 2025, then dropped by 5.52% to -$6.2 million in 2026.
  • Business Quant data shows STXS's Net Income towards Common Stockholders at -$6.2 million in Q1 2026, -$5.8 million in Q4 2025, and -$6.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 826.00 Mn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -274.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 239.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 398.73 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 135.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 13.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -77.90 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 112.77 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 2.00 Mn
10 Stereotaxis 180.48 Mn 165.86 Mn 3.79 Mn -6.17 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.17 Mn
Dec 31, 2025 -5.85 Mn
Sep 30, 2025 -6.79 Mn
Jun 30, 2025 -4.14 Mn
Mar 31, 2025 -6.14 Mn
Dec 31, 2024 -7.84 Mn
Sep 30, 2024 -6.52 Mn
Jun 30, 2024 -6.16 Mn
Mar 31, 2024 -4.84 Mn
Dec 31, 2023 -5.38 Mn
Sep 30, 2023 -5.71 Mn
Jun 30, 2023 -5.29 Mn
Mar 31, 2023 -5.68 Mn
Dec 31, 2022 -4.49 Mn
Sep 30, 2022 -5.26 Mn
Jun 30, 2022 -5.47 Mn
Mar 31, 2022 -4.42 Mn
Dec 31, 2021 -3.69 Mn
Sep 30, 2021 -4.96 Mn
Jun 30, 2021 -1.55 Mn